Calley Means

So you go into the non-dairy milk aisle and you've got 15 different options. You've got oat milk. You've got almond milk. You've got cashew milk, blah, blah, blah. And it's like... what the heck are you supposed to get? And you think you're making a good choice because you're buying an unsweetened non-dairy milk.

So you go into the non-dairy milk aisle and you've got 15 different options. You've got oat milk. You've got almond milk. You've got cashew milk, blah, blah, blah. And it's like... what the heck are you supposed to get? And you think you're making a good choice because you're buying an unsweetened non-dairy milk.

So you go into the non-dairy milk aisle and you've got 15 different options. You've got oat milk. You've got almond milk. You've got cashew milk, blah, blah, blah. And it's like... what the heck are you supposed to get? And you think you're making a good choice because you're buying an unsweetened non-dairy milk.

But the reality is from our data set that there are some of those that give you a monumental spike, even if they're unsweetened. oat milk, you know, and then there's others that actually have virtually no glucose response. So that person now can take their health into their own hand, make a consumer decision, not based on marketing that's going to serve their goals.

But the reality is from our data set that there are some of those that give you a monumental spike, even if they're unsweetened. oat milk, you know, and then there's others that actually have virtually no glucose response. So that person now can take their health into their own hand, make a consumer decision, not based on marketing that's going to serve their goals.

But the reality is from our data set that there are some of those that give you a monumental spike, even if they're unsweetened. oat milk, you know, and then there's others that actually have virtually no glucose response. So that person now can take their health into their own hand, make a consumer decision, not based on marketing that's going to serve their goals.

And I am so excited for that world because people are going to start, I think, demanding from food companies to actually create products that are not creating a huge amount of glycemic variability or these ups and down spikes. And you can't hide from that data. And so I'm really thrilled of what that's going to do.

And I am so excited for that world because people are going to start, I think, demanding from food companies to actually create products that are not creating a huge amount of glycemic variability or these ups and down spikes. And you can't hide from that data. And so I'm really thrilled of what that's going to do.

And I am so excited for that world because people are going to start, I think, demanding from food companies to actually create products that are not creating a huge amount of glycemic variability or these ups and down spikes. And you can't hide from that data. And so I'm really thrilled of what that's going to do.

So circling back to your main question of kind of like some of the themes that we've seen. Yeah, what do we see? I think one of the first things that's really interesting is our demographics, actually. So aside from glucose data, actually 52% of our beta members are women. And this is so different than what you hear in the mainstream media.

So circling back to your main question of kind of like some of the themes that we've seen. Yeah, what do we see? I think one of the first things that's really interesting is our demographics, actually. So aside from glucose data, actually 52% of our beta members are women. And this is so different than what you hear in the mainstream media.

So circling back to your main question of kind of like some of the themes that we've seen. Yeah, what do we see? I think one of the first things that's really interesting is our demographics, actually. So aside from glucose data, actually 52% of our beta members are women. And this is so different than what you hear in the mainstream media.

There's a New York Times article about levels that talks about how this is for the worried well and the biohacker guys and the longevity crazy. And it's like, that is not the reality. The reality is this is mostly women in their ages of 30 to 40. So very similar to the demographic I was talking about with people who are at high risk for things like PCOS.

There's a New York Times article about levels that talks about how this is for the worried well and the biohacker guys and the longevity crazy. And it's like, that is not the reality. The reality is this is mostly women in their ages of 30 to 40. So very similar to the demographic I was talking about with people who are at high risk for things like PCOS.

There's a New York Times article about levels that talks about how this is for the worried well and the biohacker guys and the longevity crazy. And it's like, that is not the reality. The reality is this is mostly women in their ages of 30 to 40. So very similar to the demographic I was talking about with people who are at high risk for things like PCOS.

And their primary reason for wanting to use a CGM, what they report to us is weight loss, followed by finding their optimal diet. Of men, in the 48% who are men, their number one goal is optimal diet as well. So people are clearly interested in finding what actually works for them. Okay.

And their primary reason for wanting to use a CGM, what they report to us is weight loss, followed by finding their optimal diet. Of men, in the 48% who are men, their number one goal is optimal diet as well. So people are clearly interested in finding what actually works for them. Okay.

And their primary reason for wanting to use a CGM, what they report to us is weight loss, followed by finding their optimal diet. Of men, in the 48% who are men, their number one goal is optimal diet as well. So people are clearly interested in finding what actually works for them. Okay.

If you go back to what you're talking about with COVID, the CDC just announced yesterday, finally admitted that 75% of the people dying of COVID have four or more of these largely preventable cardiometabolic comorbidities. People know, they know now, and now it's finally coming out in the mainstream media that we've got to get the blood sugar under control.

If you go back to what you're talking about with COVID, the CDC just announced yesterday, finally admitted that 75% of the people dying of COVID have four or more of these largely preventable cardiometabolic comorbidities. People know, they know now, and now it's finally coming out in the mainstream media that we've got to get the blood sugar under control.